Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK caucasian population

Arthritis and Rheumatism

Volumn 60, Issue 9, 2009, Pages 2565-2576

  Morgan, Ann W ^a,h   Thomson, Wendy ^b   Martin, Stephen G ^c   Carter, Angela M ^a   Erlich, Henry A ^c   Barton, Anne ^b   Hocking, Lynne ^d   Reid, David M ^d   Harrison, Pille ^e   Wordsworth, Paul ^e   Steer, Sophia ^f   Worthington, Jane ^b   Emery, Paul ^a   Wilson, Anthony G ^g   Barrett, Jennifer H ^a   Conaghan, Philip ^a   Keenan, Anne Maree ^a   Hensor, Elizabeth ^a   Kitcheman, Julie ^a   Quinn, Mark ⁱ   Gough, Andrew ^j   Green, Michael ^i,j   Reece, Richard ^k   Hordon, Lesley ^l   Helliwell, Philip ^m   Melsom, Richard ^l   Doherty, Sheelagh ⁿ   Adebajo, Ade ^o   Harvey, Andrew ^p   Jarrett, Steve ^p   Karim, Zunaid ^p   Huson, Gareth ^a   Martin, Mike ^a   Pease, Colin ^a   Cox, Sally ^a   Isdale, Amanda ⁱ   McGonagle, Dennis ^q   Bejarano, Victoria ^a   Nam, Jackie ^a   Brown, Claire ^a   Thomas, Christine ^a   Pickles, David ^a   Hammond, Alison ^a   Rhys Evans, Belinda ^a   Padwell, Barbara ^a   Smith, Sally ^a   King, Heather ^a   Neville, Beverley ^j   Fairclough, Alan ^k   Nunns, Caroline ^k   Gill, Anne ⁱ   Green, Julie ⁱ   Madden, Julie ^q   Taylor, Lynda ^q   Firth, Jill ^m   Sigsworth, Linda ^m   Heard, Jayne ⁿ   Corscadden, Diane ^a   Henshaw, Karen ^a   Rashid, Lubna Haroon ^a   Robinson, James I ^a   Eyre, Stephen ^b   Hinks, Anne ^b   Gibbons, Laura J ^b   Bowes, John ^b   Flynn, Edward ^b   Martin, Paul ^b   more..

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

^h UNIVERSITY OF LEEDS   (United Kingdom)

ⁱ YORK HOSPITAL   (United Kingdom)

^j HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^k HUDDERSFIELD ROYAL INFIRMARY   (United Kingdom)

^l Dewsbury District and General Hospital   (United Kingdom)

^m ST LUKE S HOSPITAL   (United Kingdom)

ⁿ HULL ROYAL INFIRMARY   (United Kingdom)

^o BARNSLEY DISTRICT GENERAL HOSPITAL   (United Kingdom)

^p PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

^q CALDERDALE ROYAL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; HLA DR ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; RHEUMATOID FACTOR;

ADULT; ALLELE; ANTIBODY PRODUCTION; ARTICLE; BIRTH; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SMOKING; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; EPITOPES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HLA-DR ANTIGENS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, GENETIC; PEPTIDES, CYCLIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RHEUMATOID FACTOR; SMOKING; YOUNG ADULT;

EID: 69449090215     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24752     Document Type: Article

References (40)

1. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 2002;41:793-800. (Pubitemid 34822963)
2. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-37 (Pubitemid 30368210)
3. MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 2002;46:632-639 (Pubitemid 34214245)
4. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford) 2007;46:49-56.
5. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678
6. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al, and the other members of the EIRA Study Group. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-841
7. Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006;119:503.e1-9 (Pubitemid 43810152)
8. Krishnan E, Sokka T, Hannonen P. Smoking-gender interaction and risk of rheumatoid arthritis. Arthritis Res Ther 2003;5:R158-62.
9. Tuomi T, Heliovaara M, Palosuo T, Aho K. Smoking, lung function, and rheumatoid factors. Ann Rheum Dis 1990;49:753-756 (Pubitemid 20346377)
10. Karlson EW, Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 1999;42:910-917
11. Masdottir B, Jonsson T, Manfredsdottir V, Vikingsson A, Brekkan A, Valdimarsson H, et al. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 2000;39:1202-1205 (Pubitemid 30942982)
12. Harrison BJ, Silman AJ. Does smoking influence disease outcome in patients with rheumatoid arthritis? J Rheumatol 2000;27:569-570
13. Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997;56:463-469 (Pubitemid 27396032)
14. Mattey DL, Dawes PT, Fisher J, Brownfield A, Thomson W, Hajeer AH, et al. Nodular disease in rheumatoid arthritis: association with cigarette smoking and HLA-DRB1/TNF gene interaction. J Rheumatol 2002;29:2313-2318 (Pubitemid 35266021)
15. Hutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis 2001;60:223-227 (Pubitemid 32260603)
16. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L, for the Epidemiological Investigation of Rheumatoid Arthritis Study Group. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004;50:3085-3092
17. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, et al, and the Epidemiological Investigation of Rheumatoid Arthritis Study Group. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
18. Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, et al. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 2006;8:R133.
19. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, van der Helm-van Mil AH, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007;80:867-875 (Pubitemid 46668455)
20. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, et al. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2006;65:366-371 (Pubitemid 43268227)
21. Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieude P, et al. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 2008;67:466-470
22. Wesoly J, van der Helm-van Mil AH, Toes RE, Chokkalingam AP, Carlton VE, Begovich AB, et al. Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. Arthritis Rheum 2005;52:2948-2950 (Pubitemid 41369126)
23. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003;171:538-541 (Pubitemid 36871358)
24. Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner, but not with HLA-SE status. Genes Immun 2005;6:129-133 (Pubitemid 40439538)
25. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007;179:4704-4710
26. Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006;18:207-213 (Pubitemid 43903283)
27. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-1319 (Pubitemid 41722185)
28. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-2749 (Pubitemid 37280601)
29. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-386
30. Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J, et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007;39:1431-1433
31. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
32. MacGregor AJ, Bamder S, Silman AJ. A comparison of the performance of different methods of disease classification for rheumatoid arthritis: results from an analysis from a nationwide twin study. J Rheumatol 1994;21:1420-1426
33. Catto AJ, Carter AM, Stickland MH, Bamford JM, Davies JA, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost 1997;77:730-734 (Pubitemid 27182972)
34. Mewar D, Coote A, Moore D, Marinou I, Keyworth J, Dickson M, et al. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther 2006;8:R128.
35. Rothman KJ. Epidemiology: an introduction. New York: Oxford University Press; 2002.
36. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-456
37. Van der Helm-van Mil AH, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008;10:205.
38. Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005;52:3433-3438 (Pubitemid 41612209)
39. Meyer O, Nicaise-Roland P, Santos MD, Labarre C, Dougados M, Goupille P, et al. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res Ther 2006;8:R40.
40. Kastbom A, Strandberg G, Lindroos A, Skogh T. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 2004;63:1085-1089 (Pubitemid 39120359)